Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Interest & Investment Income (2012 - 2026)

Updated

Kamada (KMDA) posted Interest & Investment Income of $434,000 for the quarter ended Jun 30, 2026, down 4.2% from $453,000 a year earlier but up 2.1% from the prior quarter.

Analysis

Kamada (KMDA) Interest & Investment Income (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Kamada was $1.79 million, down 22.6% year-over-year; for the year ended Dec 31, 2025, it was $1.92 million, down 9.3% from the prior year.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 13.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Kamada's Interest & Investment Income was $2.12 million in the year ended Dec 31, 2024 (+260.2%), $588,000 in the year ended Dec 31, 2023 (+546.2%), $91,000 in the year ended Dec 31, 2022 (-69.2%) and $295,000 in the year ended Dec 31, 2021 (-71.3%).
  • Quarterly Interest & Investment Income has run from a low of $1,000 in the quarter ended Jun 30, 2022 to a high of $684,000 in the quarter ended Dec 31, 2024 over five years.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last five quarters, with growth averaging 112.3% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was the quarter ended Sep 30, 2024, with growth of 864.2%; the weakest was the quarter ended Jun 30, 2022, with a decline of 99.0%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $425,000 (quarter ended Mar 31, 2026), $442,000 (quarter ended Dec 31, 2025) and $492,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kamada 479.37 Mn 188.43 Mn 22.47 Mn 434,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 434,000.00
Mar 31, 2026 425,000.00
Dec 31, 2025 442,000.00
Sep 30, 2025 492,000.00
Jun 30, 2025 453,000.00
Mar 31, 2025 534,000.00
Dec 31, 2024 684,000.00
Sep 30, 2024 646,000.00
Jun 30, 2024 508,000.00
Mar 31, 2024 280,000.00
Dec 31, 2023 496,000.00
Sep 30, 2023 67,000.00
Mar 31, 2023 25,000.00
Dec 31, 2022 59,000.00
Sep 30, 2022 29,000.00
Jun 30, 2022 1,000.00
Mar 31, 2022 2,000.00
Dec 31, 2021 18,000.00
Sep 30, 2021 68,000.00
Jun 30, 2021 99,000.00
API Access

Kamada Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KMDA&period=max&api_key=YOUR_API_KEY